1-18 of 18
Keywords: Small-cell lung cancer
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2018) 94 (4): 207–214.
Published Online: 31 January 2018
... shown amrubicin to be an effective first- or second-line treatment option for small-cell lung cancer (SCLC). However, there have been few studies reporting the efficacy of platinum-based chemotherapy after amrubicin therapy. We aimed to evaluate the efficacy of platinum-based chemotherapy as second-line...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2010) 77 (Suppl. 1): 90–96.
Published Online: 02 February 2010
...Antonio Rossi; Domenico Galetta; Cesare Gridelli The inclusion of new drugs in clinical research and practice has allowed improvements in several outcomes of advanced non-small-cell lung cancer (NSCLC). Among these drugs, very interesting results have been obtained from pemetrexed and new targeted...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (1992) 49 (Suppl. 1): 2–10.
Published Online: 26 June 2009
.... Combined modality Small-cell lung cancer Surgery Prophylactic cranial irradiation Platinum/Etoposide Therapy in Small Cell Lung Cancer Oncology 1992;49(suppl 1):2 10 Nagahiro Saijo Pharmacology Division. National Cancer Center Research Institute. Tokyo. Japan Combined Modality Therapy for Small Cell...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2005) 68 (2-3): 223–229.
Published Online: 29 July 2005
...-epirubicin-paclitaxel (PET) weekly administration with granulocyte colony-stimulating factor (G-CSF) support in chemonaive small-cell lung cancer patients with extensive disease (ED-SCLC). Methods: Chemonaive ED-SCLC patients received cisplatin 30 mg/sqm, epirubicin 50 mg/sqm and paclitaxel 120 mg/sqm...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2001) 61 (Suppl. 1): 55–59.
Published Online: 26 September 2001
...Joan H. Schiller Topotecan (HYCAMTIN ® ; GlaxoSmithKline, Brentford, Middlesex, UK) is a novel topoisomerase I inhibitor with potentially broad applicability in the treatment of solid and hematologic malignancies. In addition to its use in relapsed small-cell lung cancer (SCLC), topotecan is under...
Journal Articles
Journal Articles
Journal Articles
Journal Articles